Live from the NIH registry
Studies recruiting near Brownsville right now
Top 25 of 62 recruiting studies, sorted by proximity — each links to its official registry page
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
PreDiabetes
Phase 4
Interventional 300 participants sought
UTHealth Clinical Research Unit (CRU) at UT Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: The University of Texas Health Science Center, Houston
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Polymyositis, Dermatomyositis
Phase 3
Interventional 240 participants sought
Research Site — Harlingen, Texas (19.9 mi)
· Sponsor: AstraZeneca
Stroke Thrombectomy and Aneurysm Registry
Stroke, Thromboses, Intracranial
N/A
Observational 40,000 participants sought
Valley Baptist Medical Center — Harlingen, Texas (19.9 mi)
· Sponsor: Medical University of South Carolina
The Pivotal Study of RapidPulseTM Aspiration System
Acute Ischemic Stroke
N/A
Interventional 170 participants sought
Valley Baptist Medical Center - Harlingen — Harlingen, Texas (19.9 mi)
· Sponsor: RapidPulse, Inc
Treatment Effects on Gait in Hammertoe Patients
Hammertoe
N/A
Interventional 30 participants sought
University of Texas Rio Grande Valley — Harlingen, Texas (19.9 mi)
· Sponsor: University of Texas Rio Grande Valley
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
Primary Hyperaldosteronism
Phase 3
Interventional 250 participants sought
Research Site — Brownsville, Texas (7.1 mi)
· Sponsor: AstraZeneca
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Phase 3
Interventional 660 participants sought
USOR - Texas Oncology — Harlingen, Texas (19.9 mi)
· Sponsor: Genmab
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,200 participants sought
GSK Investigational Site — Brownsville, Texas (7.1 mi)
· Sponsor: GlaxoSmithKline
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Heart Failure
Phase 2
Interventional 620 participants sought
Headlands Horizons, LLC dba Headlands Research-Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Pfizer
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Myositis
Phase 3
Interventional 318 participants sought
Integrative Rheumatology of South Texas — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer
Phase 1, Phase 2
Interventional 132 participants sought
Texas Oncology - Central/South Texas — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
South Texas Research Institute - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Boehringer Ingelheim
Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity
Obesity, Overweight
Phase 2
Interventional 320 participants sought
Kailera Clinical Site — Brownsville, Texas (7.1 mi)
· Sponsor: Kailera
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Headlands Research Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Boehringer Ingelheim
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
South Texas Research Institute (STRI) - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
Texas Oncology - Harlingen, Medical Arts Pavillion — Harlingen, Texas (19.9 mi)
· Sponsor: Regeneron Pharmaceuticals
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Brownsville, Texas (7.1 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: 89bio, Inc.
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Gastrointestinal Neoplasms
Phase 3
Interventional 450 participants sought
GSK Investigational Site — Santa Monica, Texas (26.4 mi)
· Sponsor: GlaxoSmithKline
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Eosinophilic Esophagitis
Phase 3
Interventional 308 participants sought
Dr. Falk Investigational Site — Harlingen, Texas (19.9 mi)
· Sponsor: Dr. Falk Pharma GmbH
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Brownsville, Texas (7.1 mi)
· Sponsor: AstraZeneca
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: Akero Therapeutics, Inc
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Lupus Nephritis
Phase 4
Interventional 150 participants sought
Integrative Rheumatology of South Texas — Harlingen, Texas (19.9 mi)
· Sponsor: Aurinia Pharmaceuticals Inc.
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
COPD
Phase 2
Interventional 171 participants sought
Proactive RGV — Brownsville, Texas (7.1 mi)
· Sponsor: Uniquity One (UNI)